<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> is a rare condition (1/13,700 live births) occurring in both inherited and <z:hpo ids='HP_0003745'>sporadic</z:hpo> forms in the population </plain></SENT>
<SENT sid="1" pm="."><plain>It is manifest as a fetal <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndrome, in which <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> dominates the clinical picture </plain></SENT>
<SENT sid="2" pm="."><plain>An additional complication is that these children are predisposed to a specific subset of childhood <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, amongst which are <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour</z:e> and <z:hpo ids='HP_0006744'>adrenocortical carcinoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We report here the synthesis by an associated <z:e sem="disease" ids="C0001624" disease_type="Neoplastic Process" abbrv="">adrenal tumour</z:e> of large quantities of a high molecular weight form of insulin-like growth factor II (IGF-II), associated with profound suppression of circulating IGFs in the patient's serum </plain></SENT>
<SENT sid="4" pm="."><plain>As with other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> of this type, the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> showed loss of material on chromosome 11p </plain></SENT>
</text></document>